NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free JYNT Stock Alerts $16.44 -0.04 (-0.24%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$16.12▼$16.6050-Day Range$9.14▼$16.4852-Week Range$7.31▼$16.68Volume59,238 shsAverage Volume88,787 shsMarket Capitalization$246.17 millionP/E RatioN/ADividend YieldN/APrice Target$22.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Joint alerts: Email Address Joint MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside34.2% Upside$22.00 Price TargetShort InterestBearish5.35% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 28 Articles This WeekInsider TradingN/AProj. Earnings Growth284.62%From $0.13 to $0.50 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.95 out of 5 starsMedical Sector377th out of 915 stocksPatent Owners & Lessors Industry2nd out of 7 stocks 3.3 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days.Read more about Joint's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.35% of the outstanding shares of Joint have been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 8.8.Change versus previous monthShort interest in Joint has recently increased by 0.36%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JYNT. Previous Next 2.6 News and Social Media Coverage News SentimentJoint has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Joint this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for JYNT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Joint's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 284.62% in the coming year, from $0.13 to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is -21.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is -21.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJoint has a P/B Ratio of 9.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Joint's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Joint Stock (NASDAQ:JYNT)The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Read More JYNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JYNT Stock News HeadlinesMay 9, 2024 | americanbankingnews.comAnalysts Set The Joint Corp. (NASDAQ:JYNT) PT at $22.00May 9, 2024 | americanbankingnews.comB. Riley Brokers Boost Earnings Estimates for The Joint Corp. (NASDAQ:JYNT)May 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. May 8, 2024 | americanbankingnews.comB. Riley Increases Joint (NASDAQ:JYNT) Price Target to $20.00May 7, 2024 | globenewswire.comThe Joint Corp. to Participate in Upcoming Investor ConferencesMay 7, 2024 | americanbankingnews.comJoint (NASDAQ:JYNT) Upgraded to Buy at StockNews.comMay 7, 2024 | americanbankingnews.comJoint (NASDAQ:JYNT) Earns Buy Rating from Roth MkmMay 7, 2024 | americanbankingnews.comB. Riley Analysts Lift Earnings Estimates for The Joint Corp. (NASDAQ:JYNT)May 10, 2024 | Unstoppable Prosperity (Ad)“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. May 6, 2024 | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) Q1 2024 Earnings Call TranscriptMay 6, 2024 | americanbankingnews.comQ3 2024 EPS Estimates for The Joint Corp. Reduced by Analyst (NASDAQ:JYNT)May 4, 2024 | markets.businessinsider.comThe Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed PerformanceMay 4, 2024 | finance.yahoo.comJoint First Quarter 2024 Earnings: EPS Beats ExpectationsMay 4, 2024 | finance.yahoo.comIs The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?May 4, 2024 | cnet.comBest Banks for Joint Accounts for May 2024May 3, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Joint (JYNT)May 3, 2024 | finance.yahoo.comThe Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst ProjectionsMay 2, 2024 | investorplace.comJYNT Stock Earnings: Joint Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | globenewswire.comThe Joint Corp. Reports First Quarter 2024 Financial ResultsMay 1, 2024 | msn.comJoint Q1 2024 Earnings PreviewMay 1, 2024 | markets.businessinsider.comThe Joint earnings: here's what to expectApril 20, 2024 | seekingalpha.comThe Joint Corp. Switches Its Focus To ProfitabilityApril 18, 2024 | finance.yahoo.comThe Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 ResultsApril 18, 2024 | globenewswire.comThe Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 ResultsApril 17, 2024 | finance.yahoo.comThe Joint Chiropractic Proudly Supports Colorado-Based Rachel's ChallengeApril 17, 2024 | prnewswire.comThe Joint Chiropractic Proudly Supports Colorado-Based Rachel's ChallengeApril 17, 2024 | finance.yahoo.comThe Joint Corp. (JYNT)See More Headlines Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today5/10/2024Next Earnings (Estimated)9/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Patent owners & lessors Sub-IndustryN/A Current SymbolNASDAQ:JYNT CUSIPN/A CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees444Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$30.00 Low Stock Price Target$16.00 Potential Upside/Downside+34.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E Ratio126.23 P/E GrowthN/ANet Income$-9,750,000.00 Net Margins-9.24% Pretax Margin-0.34% Return on Equity3.94% Return on Assets1.29% Debt Debt-to-Equity RatioN/A Current Ratio1.34 Quick Ratio1.32 Sales & Book Value Annual Sales$119.12 million Price / Sales2.06 Cash Flow$0.74 per share Price / Cash Flow22.21 Book Value$1.68 per share Price / Book9.77Miscellaneous Outstanding Shares14,974,000Free Float10,425,000Market Cap$245.72 million OptionableOptionable Beta1.58 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Peter D. Holt (Age 65)CEO, President & Director Comp: $469.55kJake Singleton (Age 42)Chief Financial Officer Comp: $280.92kMr. Jorge ArmenterosSenior Vice President of OperationsMr. Charles NellesChief Technology OfficerDr. Steven KnaufVice President of Chiropractic & ComplianceMs. Lori I. Abou Habib (Age 44)Chief Marketing Officer Ms. Krischelle TennessenChief Human Resources OfficerMr. Eric SimonSenior VP of Franchise Sales & DevelopmentMr. Craig P. Colmar J.D. (Age 71)Secretary Comp: $37kMore ExecutivesKey Competitors23andMeNASDAQ:MEAVITA MedicalNASDAQ:RCELMetagenomiNASDAQ:MGXFoghorn TherapeuticsNASDAQ:FHTXVeruNASDAQ:VERUView All CompetitorsInsiders & InstitutionsFirst Foundation AdvisorsBought 33,104 shares on 5/10/2024Ownership: 1.398%Russell Investments Group Ltd.Bought 7,375 shares on 5/8/2024Ownership: 0.603%JCP Investment Management LLCBought 15,000 shares on 5/7/2024Ownership: 0.755%Bridge City Capital LLCBought 9,492 shares on 4/12/2024Ownership: 0.150%Avondale Wealth ManagementBought 12,500 shares on 4/2/2024Ownership: 0.129%View All Insider TransactionsView All Institutional Transactions JYNT Stock Analysis - Frequently Asked Questions Should I buy or sell Joint stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" JYNT shares. View JYNT analyst ratings or view top-rated stocks. What is Joint's stock price target for 2024? 4 Wall Street analysts have issued 12-month price targets for Joint's stock. Their JYNT share price targets range from $16.00 to $30.00. On average, they predict the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price. View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts. How have JYNT shares performed in 2024? Joint's stock was trading at $9.61 on January 1st, 2024. Since then, JYNT shares have increased by 70.6% and is now trading at $16.39. View the best growth stocks for 2024 here. When is Joint's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 11th 2024. View our JYNT earnings forecast. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) issued its earnings results on Thursday, March, 7th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. The business had revenue of $30.61 million for the quarter, compared to analyst estimates of $29.63 million. Joint had a positive trailing twelve-month return on equity of 3.94% and a negative net margin of 9.24%. What is Peter D. Holt's approval rating as Joint's CEO? 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE). When did Joint IPO? Joint (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Joint's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include First Foundation Advisors (1.40%), JCP Investment Management LLC (0.76%), Russell Investments Group Ltd. (0.60%), Bridge City Capital LLC (0.15%) and Avondale Wealth Management (0.13%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella. View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:JYNT) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsShocking: One AI startup's revenue could surge 4,735%Manward PressGold ManiaStansberry Research[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
